198 related articles for article (PubMed ID: 6297804)
21. Involvement of carbohydrates in vesicular stomatitis virus-cell early interaction.
Mastromarino P; Conti C; Ciuffarella MG; Orsi N
Acta Virol; 1989 Dec; 33(6):513-20. PubMed ID: 2576593
[TBL] [Abstract][Full Text] [Related]
22. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
[TBL] [Abstract][Full Text] [Related]
23. Virucidal activity presence in Trichilia glabra leaves.
Cella M; Riva DA; Coulombié FC; Mersich SE
Rev Argent Microbiol; 2004; 36(3):136-8. PubMed ID: 15559196
[TBL] [Abstract][Full Text] [Related]
24. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus.
Finkelshtein D; Werman A; Novick D; Barak S; Rubinstein M
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7306-11. PubMed ID: 23589850
[TBL] [Abstract][Full Text] [Related]
25. The activation of vaccinia virus infectivity by the transfer of phosphatidylserine from the plasma membrane.
Ichihashi Y; Oie M
Virology; 1983 Oct; 130(2):306-17. PubMed ID: 6649411
[TBL] [Abstract][Full Text] [Related]
26. Structural changes in BHK cell plasma membrane caused by the binding of vesicular stomatitis virus.
Altstiel LD; Landsberger FR
J Virol; 1981 Jul; 39(1):82-6. PubMed ID: 6268823
[TBL] [Abstract][Full Text] [Related]
27. Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response.
Ostertag D; Hoblitzell-Ostertag TM; Perrault J
J Virol; 2007 Jan; 81(2):503-13. PubMed ID: 17065213
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein.
Nikolic J; Belot L; Raux H; Legrand P; Gaudin Y; A Albertini A
Nat Commun; 2018 Mar; 9(1):1029. PubMed ID: 29531262
[TBL] [Abstract][Full Text] [Related]
29. Role of cell membrane composition in receptor-mediated internalization of vesicular stomatitis virus in human HEp-2 cells.
Pottathil R; Gutierrez PL; Davis LH; Chandrabose KA
J Biol Chem; 1985 May; 260(9):5265-70. PubMed ID: 2985585
[TBL] [Abstract][Full Text] [Related]
30. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
Maheshwari RK; Friedman RM
J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
[TBL] [Abstract][Full Text] [Related]
31. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
Závadová Z; Závada J
Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
[TBL] [Abstract][Full Text] [Related]
32. The Propagation, Quantification, and Storage of Vesicular Stomatitis Virus.
Abdelmageed AA; Ferran MC
Curr Protoc Microbiol; 2020 Sep; 58(1):e110. PubMed ID: 32833351
[TBL] [Abstract][Full Text] [Related]
33. Role of viral envelope sialic acid in membrane fusion mediated by the vesicular stomatitis virus envelope glycoprotein.
Puri A; Grimaldi S; Blumenthal R
Biochemistry; 1992 Oct; 31(41):10108-13. PubMed ID: 1327132
[TBL] [Abstract][Full Text] [Related]
34. Effects of thyroid-stimulating hormone on the replicative cycle of vesicular stomatitis virus in primary cultured sheep thyroid cells.
Eggo MC; Vitale MA; Petric M; Burrow GN
Biochimie; 1999 Apr; 81(4):291-6. PubMed ID: 10401661
[TBL] [Abstract][Full Text] [Related]
35. Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation.
Kaptur PE; McKenzie MO; Wertz GW; Lyles DS
Virology; 1995 Feb; 206(2):894-903. PubMed ID: 7856102
[TBL] [Abstract][Full Text] [Related]
36. Monensin-resistant mouse Balb/3T3 cell mutant with aberrant penetration of vesicular stomatitis virus.
Ono M; Mifune K; Yoshimura A; Ohnishi S; Kuwano M
J Cell Biol; 1985 Jul; 101(1):60-5. PubMed ID: 2861207
[TBL] [Abstract][Full Text] [Related]
37. Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions.
Carneiro FA; Bianconi ML; Weissmüller G; Stauffer F; Da Poian AT
J Virol; 2002 Apr; 76(8):3756-64. PubMed ID: 11907215
[TBL] [Abstract][Full Text] [Related]
38. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
Dargan DJ; Galt CB; Subak-Sharpe JH
J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
[TBL] [Abstract][Full Text] [Related]
39. Mode of antiviral activity of water soluble components isolated from Elfvingia applanata on vesicular stomatitis virus.
Eo SK; Kim YS; Oh KW; Lee CK; Lee YN; Han SS
Arch Pharm Res; 2001 Feb; 24(1):74-8. PubMed ID: 11235816
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of vesicular stomatitis virus by kethoxal bis (thiosemicarbazone).
Levinson W; Oppermann H; Jackson J
J Gen Virol; 1977 Oct; 37(1):183-90. PubMed ID: 72131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
